Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

Newsletter
  July 12, 2008  
  Volume IX, Issue 49  
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

How Ugly Can Work For You in Earnings Season

This market environment is giving me flashbacks of the Post 911/Dot Bomb meltdown era. It is simply an ugly Bear Market, and with each successive trading day it just seems to get uglier. 

If you are long any stocks today, you simply need to have a long term perspective. Everything I cover has further downside risk in today's environment. There are simply no buyers around, and as investors see stocks trade down to levels they can no longer stomach, small sell side trades lead to eroding values against a backdrop of a complete buyers strike.

I've been counseling all investors to decide if you want to hold your stocks for through this down cycle and re evaluate when conditions improve. Indeed- consider carefully- do you have a long term mentality and the ability to not worry too much about today's quote? If so, hang in there on the stories you like. If not, get out, and wait it out. This won't last forever, and there will be some easy money to be made in the first surge when conditions improve. Micros will trade up as if in a vacuum. I just can't say when it will happen, and how low we will go before it does.

In the meantime, I suspect most of the microcap audience hasn't been paying attention to some of the short term trading ideas I have provided in this market meltdown. For speculators, there is always somewhere profits can be had, and with the micro side dead for the time being, I have turned my attention to short term trades.

Here's a table of the trades I have published since Mid May. These are the actual trades I have executed in my own account:
 

Stock
Date Bought
Date Sold
Net Profit
1,000 QQQQ
5/15
5/15
$23.82
1,000 QQQQ
5/15
5/20
$133.82
50 QQQQ July 50 Puts
6/5
6/6
$1509.05
20 QQQQ July 50 Puts
6/5
6/9
$74.09
50 QQQQ July 49 Puts
6/17
6/19
$1209.05
1,0000 QID
5/15
6/19
$1369.85
1,0000 QID
5/15
6/19
$1319.85
10 RIMM Aug 110 Calls
7/3
7/8
$2159.01

This all adds up to a net profit of $7798.54 net including commissions and trade fees. These are all trades I published in the BLOG which you could have participated in as well. 

So, despite the market driven carnage in microcap land, there are trades to be had. Of course, for those of you who have been following my suggestion to participate in QID, that's my major regret. I chose to liquidate that position out in front of my vacation as I couldn't monitor the market. Needless to say, QID went directly to my target price of $45 to $46, and I left about $10,000 on the table. That was one expensive vacation. I hope some of you took advantage of the idea and made some money.

Now, on to an idea about how to make some money in the coming earnings season.
 

  Earnings Disappointments and Subsequent Thrashings  

Have you ever watched a stock get absolutely decimated after an earnings release? It's a pattern that repeats itself, and is likely to be exacerbated over the next several weeks in this hair trigger market environment.

When companies disappoint the market with even the slightest miss, the market ruthlessly opens the stocks much lower, and they often drop from there. Wall Street flushes them down the toilet in one fell swoop. Consider Research in Motion (NASDAQ: RIMM)- the manufacturer of the Blackberry. A couple of weeks ago the company missed its Wall Street earnings estimate my a whisker- the stock shed nearly 20 points almost instantaneously.

As we move into earnings season, I believe the current market environment could lead to some huge gains with companies that disappoint if you get on the short side, particularly if the stocks run up into the earnings report.

Below is a table I plan to use going into earnings season. I plan to look for stocks that run up a little into their earnings releases, and take a short position of buy a put option before they release numbers. I believe it is very important that the stocks run up a little into their earnings releases. This will set the stocks up for a better chance of a pullback. Even on good numbers, speculators could be taking profits and running stocks down. I've come up with 20 names to monitor over the next 10 days.
 

Date
Company
Ticker Symbol
EPS Estimate
Time of Release
7/14
Genetech
DNA
.86
Post Close
7/15
Altera
ALTR
.27
Post Close
71/5
JB Hunt
JBHT
.36
Unknown
7/16
Abbot Labs
ABT
.79
Pre Open
7/16
St. Jude Medical
STJ
.55
Pre Open
7/16
eBay
EBAY
.41
unknown
7/17
Cypress Semi
CY
.21
unknown
7/17
Google
GOOG
4.73
post close
7/17
United Technologies
UTX
1.30
Pre Open
7/18
Schlumberger
SLB
1.12
pre open
7/21
Apple
AAPL
1.07
post close
7/21 
Boston Scientific
BSX
.11
post close
7/21
Logitech
LOGI
.19
post close
7/22
Caterpillar
CAT
1.54
pre open
7/22
CheckPoint
CHKP
.43
pre open
7/22
Panera Bread
PNRA
.49
post close
7/22
Yahoo
YHOO
.12
post close
7/23
Anheuser Busch
BUD
.93
unknown
7/23
General Dynamics
GD
1.44
unkonwn
7/23
Sybase
FY
.43
unknown

If you're interested in following these trading ideas, check the BLOG everyday just after the market closes. I'll provide a recap of what I am doing with my own capital, and try to notch some big profits.

The OTC Journal is all about making money in the speculative end of your portfolio. Anyone with a feeling for market cycles knows there are times when the environment makes it nearly impossible to profit on small stocks. We are in one of those times right now. 

However, as long as stocks are moving, there are ways to make money. I only plan to risk small amounts on these trades when they set up properly. This is an experiment. I'm adjusting my thinking to the market environment. 

Keep an eye on the BLOG everyday for trading ideas. I'll track them, and see how they come out. This could be a profitable course to pursue, especially if you catch a couple of trades for 10 to 20 point gains.

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com
 

  Subscribe  

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

  Refer A Friend  

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.


  Ensure Newsletter Delivery  

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Disclaimer
The OTC Journal Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.


You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt/?.

 

Click Here to View the OTC Journal Disclosure

China Energy Recovery, Inc.
Newsletter
Editions
RSS Subscribe

To subscribe to our newsletter, please enter your email address below.

OTCJ: Chu On This
December 16, 2008

Market Summary
Dow 8952.89 -81.80 (-0.91%)
Nasdaq 1628.03 -4.18 (-0.26%)
Russell 2K 505.03 -0.81 (-0.16%)
S&P 500 927.45 -4.35 (-0.47%)
S&P 100 440.83 -3.69 (-0.83%)
Quotes are delayed 20 minutes.

© 2009 OTC Journal